Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9340ca221efd6521aa0f3b28478f1866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0dfc733767353e22020103bddcb121e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d5984e9184a918ee49d3298922311de http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab5cf42bdc1e0e3f095bf3705762ea1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2312ca10a8750b1e885cd0bf57d7178b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-635 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-635 |
filingDate |
1994-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9ff93dade7f62942abe57868706d081 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1754535c7ca22a669967b86962b5e5b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c219314cc3b62478bef407108e6d98b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_642cbdb0d3ede8aa124dff229fe76ccd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_640755d8f2c2f55598dca839200de63e |
publicationDate |
1995-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2126299-A1 |
titleOfInvention |
Parathyroid Hormone Analogues for the Treatment of Osteoporosis |
abstract |
Certain analogues of human parathyroid hormone (hPTH) have been found to be effective for the treatment of osteoporosis, while showing decreased side effects. Analogues showing this effect include all sequences from hPTH-(1-28)-NH2 to hPTH- (1-31)-NH2 and all sequences from [Leu27]-hPTH-(1-28)-NH2 to [Leu27]-hPTH-(1-34)-NH2. Also included are cyclic analogues cyclo(Lys26-Asp30)[Leu27]-hPTH-(1-34)NH2 and cyclo (Lys27-Asp30)- hPTH-(1-34)-NH2. Analogues in the form of the carboxyl terminal amide are particularly effective. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9805683-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6417333-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1352912-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7479478-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009057386-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8088734-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9057727-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6803213-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9492508-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7169567-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0031266-A1 |
priorityDate |
1994-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |